IT1182150B - Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono - Google Patents

Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono

Info

Publication number
IT1182150B
IT1182150B IT47600/85A IT4760085A IT1182150B IT 1182150 B IT1182150 B IT 1182150B IT 47600/85 A IT47600/85 A IT 47600/85A IT 4760085 A IT4760085 A IT 4760085A IT 1182150 B IT1182150 B IT 1182150B
Authority
IT
Italy
Prior art keywords
tetraidrocarbozolonici
procedures
preparing
pharmaceutical compositions
compositions containing
Prior art date
Application number
IT47600/85A
Other languages
English (en)
Italian (it)
Other versions
IT8547600A0 (it
Inventor
Jan Harold Coates
James Angus Bell
David Cedric Humber
Ewan George Blanch
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848401888A external-priority patent/GB8401888D0/en
Priority claimed from GB848425959A external-priority patent/GB8425959D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT8547600A0 publication Critical patent/IT8547600A0/it
Application granted granted Critical
Publication of IT1182150B publication Critical patent/IT1182150B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT47600/85A 1984-01-25 1985-01-25 Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono IT1182150B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848401888A GB8401888D0 (en) 1984-01-25 1984-01-25 Heterocyclic compounds
GB848425959A GB8425959D0 (en) 1984-10-15 1984-10-15 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
IT8547600A0 IT8547600A0 (it) 1985-01-25
IT1182150B true IT1182150B (it) 1987-09-30

Family

ID=26287221

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47600/85A IT1182150B (it) 1984-01-25 1985-01-25 Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono

Country Status (29)

Country Link
KR (1) KR920003064B1 (un)
AT (1) AT392276B (un)
AU (1) AU579132B2 (un)
BE (1) BE901576A (un)
CA (1) CA1252793A (un)
CH (1) CH664152A5 (un)
CY (1) CY1479A (un)
CZ (1) CZ404391A3 (un)
DE (2) DE19375046I2 (un)
DK (1) DK169521B1 (un)
ES (3) ES8609309A1 (un)
FI (1) FI84349C (un)
FR (1) FR2561244B1 (un)
GB (1) GB2153821B (un)
GR (1) GR850219B (un)
HK (1) HK33189A (un)
HU (1) HU193592B (un)
IE (1) IE57809B1 (un)
IL (1) IL74165A (un)
IT (1) IT1182150B (un)
LU (2) LU85743A1 (un)
NL (2) NL190373C (un)
NO (2) NO164025C (un)
NZ (1) NZ210940A (un)
PH (1) PH22672A (un)
PT (1) PT79890B (un)
SE (1) SE460359B (un)
SG (1) SG7089G (un)
SK (1) SK277923B6 (un)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
AU583343B2 (en) * 1985-01-23 1989-04-27 Glaxo Group Limited Heterocyclic compounds
DE3688296T2 (de) * 1985-03-14 1993-11-04 Beecham Group Plc Arzneimittel zur behandlung von erbrechen.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
GB8518658D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Medicaments
US5204356A (en) * 1985-07-24 1993-04-20 Glaxo Group Limited Treatment of anxiety
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518745D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
AT396870B (de) * 1986-08-07 1993-12-27 Sandoz Ag Verfahren zur herstellung einer galenischen formulierung zur nasalen verabreichung von serotoninantagonisten
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
JP2765845B2 (ja) * 1986-11-21 1998-06-18 グラクソ、グループ、リミテッド 中止症候群の予防の治療薬
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
US5202343A (en) * 1986-11-28 1993-04-13 Glaxo Group Limited Tricyclic ketones useful as HT3 -receptor antagonists
GB8812002D0 (en) * 1988-05-20 1988-06-22 Glaxo Group Ltd Chemical compounds
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
US5200414A (en) * 1986-12-17 1993-04-06 Glaxo Group Limited Methods for the treatment of cognitive disorders
US5190954A (en) * 1986-12-17 1993-03-02 Glaxo Group Limited Methods for the treatment of cognitive disorders
US4973594A (en) * 1986-12-17 1990-11-27 Glaxo Group Limited Medicaments
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
IE60991B1 (en) * 1986-12-17 1994-09-07 Glaxo Group Ltd Use of ketone derivatives in the treatment of cognitive disorders
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
EP0291172B1 (en) * 1987-04-14 1992-11-19 Glaxo Group Limited Ketone derivatives
GB2205745B (en) * 1987-06-16 1990-09-19 Nat Res Dev Use of dioxopiperidine derivatives as analgesics
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8723157D0 (en) * 1987-10-02 1987-11-04 Beecham Group Plc Compounds
US4939144A (en) * 1987-10-22 1990-07-03 Glaxo Group Limited Tricyclic ketone derivatives as 5-HT antagonists
CA1304082C (en) * 1987-10-22 1992-06-23 Tetsuya Tahara Benzoxazine compounds and pharmaceutical use thereof
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
JPH0249772A (ja) * 1988-04-07 1990-02-20 Glaxo Group Ltd イミダゾール誘導体
DK185489A (da) * 1988-04-22 1989-10-23 Duphar Int Res Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
JPH0256485A (ja) * 1988-04-27 1990-02-26 Glaxo Group Ltd ラクタム誘導体
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
US5173493A (en) * 1988-09-27 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Pyridoindole derivatives and processes for preparation thereof
US5290785A (en) * 1988-09-27 1994-03-01 Fujisawa Pharmaceutical Co., Ltd. Therapeutic agent for ischemic diseases
FR2639944B1 (fr) * 1988-12-06 1991-01-18 Adir Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5223625A (en) * 1988-12-22 1993-06-29 Duphar International Research B.V. Annelated indolo [3,2,-C]lactams
EP0377238A1 (en) * 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
CA2004911A1 (en) * 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives
KR900013959A (ko) * 1989-03-13 1990-10-22 원본미기재 γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
JPH0669963B2 (ja) * 1989-04-21 1994-09-07 サンド・アクチエンゲゼルシャフト ５ｈｔ▲下３▼受容体拮抗薬の治療的用途
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
GB8917557D0 (en) * 1989-08-01 1989-09-13 Glaxo Group Ltd Medicaments
US5276050A (en) * 1989-08-01 1994-01-04 Glaxo Group Limited Medicaments
US5126343A (en) * 1989-09-11 1992-06-30 G. D. Searle & Co. N-azabicyclo [3.3.0]octane amides of aromatic acids
GB2236751B (en) 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
WO1993000074A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
ES2043535B1 (es) * 1992-03-13 1994-08-01 Vita Invest Sa Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
HU212934B (en) 1992-10-14 1996-12-30 Richter Gedeon Vegyeszet Process for producing novel alkoxalylated carbazolone derivatives
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
JPH08507514A (ja) * 1993-03-08 1996-08-13 藤沢薬品工業株式会社 脳血管性疾患を治療または予防するための薬物
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB2290963A (en) * 1994-06-28 1996-01-17 Kenneth Francis Prendergast Pharmaceutical uses of ondansetron
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US5969137A (en) * 1996-09-19 1999-10-19 Virginia Commonwealth University Benzylamidine derivatives with serotonin receptor binding activity
US6548082B1 (en) 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
MXPA04010846A (es) 2002-04-29 2005-01-25 Biogal Gyogyszergyar Proceso para preparar 1, 2, 3, 9-tetrahidro -9- metil-3 -[(2-metil -1h-imidazol -1-il) metil]- 4h- carbazol -4- ona.
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
GB2398071B (en) * 2003-01-24 2006-06-07 Synthon Bv Process for making ondansetron and intermediate thereof
ES2238001B1 (es) * 2004-01-21 2006-11-01 Vita Cientifica, S.L. Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
WO2005108392A2 (en) 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20090170872A1 (en) * 2005-07-05 2009-07-02 Orchid Research Laboratories Limited Compounds and Their Pharmaceutical Use
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
ES2664599T3 (es) 2009-05-20 2018-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonistas del receptor 5-HT3 de serotonina para uso en el tratamiento de trastornos vestibulares lesionales
CN115611864A (zh) * 2022-11-01 2023-01-17 常州兰陵制药有限公司 一种昂丹司琼类化合物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634420A (en) * 1969-05-09 1972-01-11 American Cyanamid Co 3(morpholinomethyl)-2 3-dihydro-carbazol-4(1h)-ones
US3740404A (en) * 1969-05-09 1973-06-19 American Cyanamid Co Piperidinomethylenedihydrocarbazolones
AU583343B2 (en) * 1985-01-23 1989-04-27 Glaxo Group Limited Heterocyclic compounds

Also Published As

Publication number Publication date
SK404391A3 (en) 1995-08-09
GB8501889D0 (en) 1985-02-27
CZ404391A3 (en) 1993-04-14
AT392276B (de) 1991-02-25
AU579132B2 (en) 1988-11-17
DE3502508A1 (de) 1985-08-14
NO850300L (no) 1985-07-26
DE3502508C2 (un) 1990-05-03
NL190373C (nl) 1994-02-01
SE8500368L (sv) 1985-07-26
DK35785A (da) 1985-07-26
IL74165A (en) 1988-11-15
ATA20485A (de) 1990-08-15
PT79890A (en) 1985-02-01
LU85743A1 (fr) 1986-08-04
ES8609309A1 (es) 1986-07-16
NO164025B (no) 1990-05-14
SG7089G (en) 1989-06-09
HUT37784A (en) 1986-02-28
LU88268I2 (un) 1994-02-03
PH22672A (en) 1988-11-14
NZ210940A (en) 1989-08-29
IE850187L (en) 1985-07-25
FI850323L (fi) 1985-07-26
FR2561244A1 (fr) 1985-09-20
AU3809785A (en) 1985-08-01
PT79890B (en) 1987-02-03
FI84349C (fi) 1991-11-25
GB2153821B (en) 1988-01-20
NO1994022I1 (no) 1994-11-09
KR920003064B1 (ko) 1992-04-13
CA1252793A (en) 1989-04-18
HU193592B (en) 1987-11-30
KR850005439A (ko) 1985-08-26
NL8500202A (nl) 1985-08-16
DE19375046I2 (de) 2002-10-10
NL190373B (nl) 1993-09-01
SE8500368D0 (sv) 1985-01-25
ES8708224A1 (es) 1987-10-01
ES548430A0 (es) 1987-10-01
BE901576A (fr) 1985-07-25
IT8547600A0 (it) 1985-01-25
FR2561244B1 (fr) 1988-03-04
FI850323A0 (fi) 1985-01-25
ES556101A0 (es) 1987-12-16
ES539852A0 (es) 1986-07-16
DK35785D0 (da) 1985-01-25
SE460359B (sv) 1989-10-02
GR850219B (un) 1985-05-23
NL940009I2 (nl) 1999-05-03
DK169521B1 (da) 1994-11-21
ES8801247A1 (es) 1987-12-16
NL940009I1 (nl) 1994-07-18
FI84349B (fi) 1991-08-15
CH664152A5 (fr) 1988-02-15
CY1479A (en) 1989-07-21
HK33189A (en) 1989-04-28
GB2153821A (en) 1985-08-29
IE57809B1 (en) 1993-04-21
NO164025C (no) 1990-08-22
SK277923B6 (en) 1995-08-09

Similar Documents

Publication Publication Date Title
IT1182150B (it) Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono
IT8348422A0 (it) Composti eterociclici, procedimento per prpararli e composizioni farmaceutiche che li contengono
IT8248157A0 (it) Composti aril-ciclobutil-amminici sostituiti, procedimenti per prepararli, composti intermedi e composizioni farmaceutiche che li contengono
IL68618A0 (en) Heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
IT8548551A0 (it) Antiparassitarie che li contengono composti antibiotici, composizioni e procedimento per prepararli ed applicarli
DE3163938D1 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IT8548348A0 (it) Derivati di amminofenolo,procedimento per prepararli e composizione farmaceutica che li contiene
IT8548093A0 (it) Eteri amminociclopentilici, procedimento per prepararli e composizione farmaceutica che li comprende
IT1209615B (it) Composizione farmaceutica
GB8417170D0 (en) Heterocyclic pharmaceutical compounds
IL60813A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
DK209384A (da) 4-phenyl-tetrahydro-furano-pyridiner og syreadditionssalte deraf, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
IT1177981B (it) Amminociclopentani, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione
SG62087G (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IT8148901A0 (it) Composti amminosteroidi composizioni farmaceutiche che li contengono e procedimento per prepararli
IL70273A (en) N-(substituted alkyl)acridanone-2-thiazole-2-yl-hydrazone derivatives,their manufacture and pharmaceutical compositions containing them
ZA814364B (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
DK512185D0 (da) 3,4-diazolderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
ZA851948B (en) New substituted isochromanes and oxpines,the acid addition salts thereof,pharmaceutical compositions containing them and processes for preparing them
IT8247590A0 (it) Composti eterociclici pirimidinici, composizione farmaceutica che li contiene e procedimento per prepararli
IT8748421A0 (it) Composti di cefalosporina,procedimento per produrli e composizioni farmaceutiche che li contengono
DK181385D0 (da) Heterocycliske pyranoderivater, fremgangsmaade til fremstilling derafog laegemiddel indeholdende saadanne forbindelser
IT1181736B (it) Derivati di imidazopiridazina,composizione farmaceutica che li contiene e procedimento per prepararli
IT8247591A0 (it) Composti eterociclici pirimidinici, composizione che li contiene e procedimento per prepararli
IT1136971B (it) Composti eterociclici azotati,procedimento per la loro preparazione e composizione farmaceutica che contiene detti composti

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 221

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 221, 19920504; GLAXO GROUP LIMITED

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960129